Get the Stockscreener App
81.59
1.13%
0.91
Solventum Corp stock is traded at $81.59, with a volume of 3.26M.
It is up +1.13% in the last 24 hours and up +5.54% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$80.68
Open:
$80.8
24h Volume:
3.26M
Relative Volume:
2.96
Market Cap:
$14.15B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
37.77
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
-1.68%
1M Performance:
+5.54%
6M Performance:
+12.34%
1Y Performance:
+22.14%
1-Day Range:
$80.54
$81.68
1-Week Range:
$79.76
$84.00
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
81.59 | 13.99B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
572.47 | 199.19B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.59 | 55.57B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.97 | 39.05B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.94 | 35.40B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.65 | 31.09B | 0 | 0 | 0 | 0.00 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Solventum Announces the Considers Recommendations of an International, Multidisciplinary Panel of Surgery and Wound Care experts on the Clinical Use of Closed Incision Negative Pressure Therapy with Reticulated Open Cell Foam Dressings - marketscreener.com
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum earns diamond level supply chain certification for healthcare By Investing.com - Investing.com Australia
Solventum earns diamond level supply chain certification for healthcare - Investing.com
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Financial Times
3M at a Crossroads: Strategic Moves and Persistent Headwinds - AD HOC NEWS
Solventum Corporation Reflects on Transformative Year - TipRanks
Wells Fargo Adjusts Price Target on Solventum to $86 From $72, Maintains Equalweight Rating - marketscreener.com
Solventum Corp Reflects on Year of Growth and Transformation - TradingView — Track All Markets
Is Solventum Stock Outperforming the Nasdaq? - Yahoo Finance
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
683 Capital Management LLC Has $493,000 Stake in Solventum Corporation $SOLV - MarketBeat
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat
Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not - Seeking Alpha
Amundi Has $19.79 Million Position in Solventum Corporation $SOLV - MarketBeat
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Should You Add Solventum Corp (SOLV) to Your Portfolio? - Insider Monkey
iSAM Funds UK Ltd Increases Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum (SOLV): Reassessing Valuation After a Strong Year-to-Date Rally and Recent Pullback - Yahoo Finance
Solventum Corporation (SOLV): A Bull Case Theory - Insider Monkey
Solventum Corporation (SOLV): A bull case theory - MSN
Solventum (SOLV): Rethinking Valuation After a 25% Year-to-Date Share Price Rally - simplywall.st
U.S. Dental Prosthetics Market Intelligence Report 2025-2033 Featuring Dentsply Sirona, 3D Systems, Solventum, Ivoclar Vivadent, Institut Straumann and MoreResearchAndMarkets.com - Business Wire
Invesco Ltd. Sells 36,589 Shares of Solventum Corporation $SOLV - MarketBeat
Innovation, Responsibility To Drive Healthcare Development - Mexico Business News
Solventum Corporation (SOLV) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Solventum Corporation (NYSE:SOLV) Surges 26% Yet Its Low P/E Is No Reason For Excitement - simplywall.st
Will Solventum Corporation stock beat international competitionJobs Report & Momentum Based Trading Signals - Newser
Franklin Resources Inc. Has $1.95 Million Position in Solventum Corporation $SOLV - MarketBeat
Is It Too Late to Consider Solventum After Its 29.3% Year To Date Rally? - Yahoo Finance
Solventum (NYSE:SOLV) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
What is the fair value estimate for Solventum Corporation (KB7) stock in 2025Quarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Arrowstreet Capital Limited Partnership Lowers Position in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation's (NYSE:SOLV) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - 富途牛牛
Officer Kirberger Acquires 2,301 Of Solventum Corp [SOLV] - TradingView
Solventum (NYSE:SOLV) Reaches New 12-Month HighWhat's Next? - MarketBeat
Skandinaviska Enskilda Banken AB publ Trims Stake in Solventum Corporation $SOLV - MarketBeat
1,852,513 Shares in Solventum Corporation $SOLV Bought by Norges Bank - MarketBeat
Korea Investment CORP Grows Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation $SOLV Position Boosted by Independent Franchise Partners LLP - MarketBeat
Why Solventum Corporation stock stays resilient2025 Price Action Summary & Step-by-Step Trade Execution Guides - Newser
Advisors Asset Management Inc. Lowers Stake in Solventum Corporation $SOLV - MarketBeat
What macro factors could drive Solventum Corporation (KB7) stock higherQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - Newser
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
2.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):